Copyright
©2010 Baishideng Publishing Group Co.
World J Cardiol. Jul 26, 2010; 2(7): 171-186
Published online Jul 26, 2010. doi: 10.4330/wjc.v2.i7.171
Published online Jul 26, 2010. doi: 10.4330/wjc.v2.i7.171
Figure 1 Pathways of platelet activation and mechanism of action of antiplatelet agents[2].
COX: Cyclooxygenase; GP: Glycoprotein; TxA2: Thromboxane A2; ASA: Acetylsalicylic acid; NSAIDs: Nonsteroidal anti-inflammatory drugs; PAF: Platelet-activating factor.
Figure 2 The clinical importance of aspirin resistance[30].
Figure 3 The possible background of aspirin resistance[38].
COX: Cyclooxygenase.
Figure 4 Possible genetical background of clopidogrel resistance[82].
GP: Glycoprotein.
- Citation: Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Papp E, Szapary L, Kesmarky G, Toth K. Clinical importance of aspirin and clopidogrel resistance. World J Cardiol 2010; 2(7): 171-186
- URL: https://www.wjgnet.com/1949-8462/full/v2/i7/171.htm
- DOI: https://dx.doi.org/10.4330/wjc.v2.i7.171